DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

MannKind Corp (NASDAQ: MNKD)

2.08 -0.12 (-5.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $2.08 -5.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.16
Previous Close $2.19
Daily Range $2.07 - $2.18
52-Week Range $1.76 - $7.88
Market Cap $849.7M
P/E Ratio -6.84
Dividend (Yield) $0.00 (0.0%)
Volume 2,251,134
Average Daily Volume 8,470,402
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary

3 Earnings Reports That Surprised Us This Quarter

Visa, MannKind, and WOOF top the list of surprises for these Motley Fool contributors.

NASDAQ Companies With Largest Short Interest

MannKind: Weekly Data Updates- 11-13-15 Data

MannKind (MNKD) Stock Gains After CEO Resigns

MannKind Elder Abuse Is Replacing Inept CEO With Founder

Benzinga's Top #PreMarket Losers

MannKind's Desperation Move Comes Up Short -- Now What?

MannKind's stock offering in Israel misses the mark, leaving the company with few viable options left to raise capital.

Why MannKind's Listing in Israel Might Not Matter

A listing in Israel may provide some cash, but it's unlikely to be enough unless sales of Afrezza ramp.

MannKind (MNKD) Shows Strength: Stock Moves Up 18.9%

MannKind Share Sale Strategy

See More MNKD News...

MNKD's Top Competitors

MNKD $2.08 (-5.25%)
Current stock: MNKD
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
CELG $112.75 (0.36%)
Current stock: CELG